m 79175 has been researched along with tolrestat in 2 studies
Studies (m 79175) | Trials (m 79175) | Recent Studies (post-2010) (m 79175) | Studies (tolrestat) | Trials (tolrestat) | Recent Studies (post-2010) (tolrestat) |
---|---|---|---|---|---|
43 | 0 | 1 | 198 | 25 | 14 |
Protein | Taxonomy | m 79175 (IC50) | tolrestat (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.0244 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.2689 | |
Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | 1.1533 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.2303 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.096 | |
Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 0.043 | |
Aldo-keto reductase family 1 member A1 | Sus scrofa (pig) | 1.365 | |
Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | 1.21 | |
Aldo-keto reductase family 1 member B1 | Sus scrofa (pig) | 0.0225 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.03 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hotta, N; Sakamoto, N | 1 |
Kador, PF; Kinoshita, JH; Sharpless, NE | 1 |
2 review(s) available for m 79175 and tolrestat
Article | Year |
---|---|
[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
Topics: Aldehyde Reductase; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Humans; Imidazoles; Imidazolidines; L-Iditol 2-Dehydrogenase; Naphthalenes; Phthalazines; Sugar Alcohol Dehydrogenases | 1987 |
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Models, Animal; Fluorenes; Galactose; Humans; Hydantoins; Imidazoles; Imidazolidines; Models, Molecular; Naphthalenes; Phthalazines; Rhodanine; Sorbitol; Structure-Activity Relationship; Substrate Specificity; Sugar Alcohol Dehydrogenases; Thiazolidines; Tissue Distribution | 1985 |